Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Olfactory neuroblastoma (ONB) is a rare malignant tumor originating from the olfactory neuroepithelium, typically within the sinonasal cavity. Cases of ONB originating outside of the olfactory cleft area are extremely rare and are referred to as "ectopic" (eONB), in contrast to "orthotopic" tumors (oONB). ONB has been associated with paraneoplastic syndromes (PNSs), including the syndrome of inappropriate antidiuretic hormone secretion (SIADH). This study investigate the association between eONB and SIADH and compared the prognosis of eONB to oONB.

Methods: A systematic literature review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted, focusing on studies reporting eONB and oONB associated with SIADH. Data from four newly identified eONB cases were reported and a pooled analysis was performed. Statistical analyses were conducted to evaluate the prevalence of SIADH in eONB and oONB and to compare clinical outcomes in the two groups.

Results: eONB had a significantly higher prevalence of SIADH (18.3%) compared to oONB (2.0%; p < 0.0001). Patients with eONB were younger, with a slight predominance of females. Recurrence-free survival and time-to-recurrence of eONB were worse than oONB, independently of other prognosticators.

Conclusions: eONB is associated with a significantly higher incidence of SIADH than oONB, suggesting distinct biological characteristics. Moreover, patients with eONB had worse prognostic outcomes. Further research is needed to understand the underlying mechanisms and improve management strategies for eONB.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697229PMC
http://dx.doi.org/10.1002/alr.23502DOI Listing

Publication Analysis

Top Keywords

olfactory neuroblastoma
8
syndrome inappropriate
8
inappropriate antidiuretic
8
antidiuretic hormone
8
hormone secretion
8
pooled analysis
8
originating olfactory
8
eonb oonb
8
prevalence siadh
8
eonb
7

Similar Publications

Background/aim: Systemic therapy for olfactory neuroblastoma with unresectable multi-recurrence disease is unestablished. However, peptide receptor radionuclide therapy (PRRT) with 177Lu-pentetreotide is considered to be an effective systemic treatment for unresectable multi-recurrence olfactory neuroblastoma expressing somatostatin receptors. This study investigated the association between survival outcome and treatment modality in olfactory neuroblastoma, with a focus on peptide receptor radionuclide therapy.

View Article and Find Full Text PDF

Oropharyngeal squamous cell carcinoma (OPSCC) presents prognostic and therapeutic challenges. Trophoblast cell surface antigen 2 (TROP2) is a transmembrane glycoprotein involved in oncogenic signaling pathways and has been explored as a therapeutic target in many solid tumors. This study aims to evaluate the prevalence and prognostic significance of TROP2 expression in OPSCC and explore its association with the tumor immune microenvironment composition.

View Article and Find Full Text PDF

Background: Anterior skull base surgery to address tumor, trauma, or infection causing extensive bony destruction is associated with rhinorrhea and infection as potentially life-threatening complications. When performing anterior skull base reconstruction, watertight dural closure and airtight closure of the nasal cavity mucosa are essential for preventing these complications.

Observations: The authors describe the case of a patient with a mixed olfactory neuroblastoma and adenocarcinoma who underwent resection.

View Article and Find Full Text PDF

Background Esthesioneuroblastoma (ENB), or olfactory neuroblastoma, is a rare malignancy arising from the olfactory epithelium. Standardized treatment protocols are lacking, and existing knowledge is largely derived from retrospective case series.  Methods  This study was undertaken to evaluate treatment outcomes and toxicities associated with multimodal therapy in a rare malignancy.

View Article and Find Full Text PDF

Background: Hyams grading is considered prognostic in olfactory neuroblastoma (ONB), but grading criteria are subjective and predate modern classification and surgical approach. We evaluate the application of granular grading criteria to an endoscopic surgery predominant cohort with extended follow-up.

Methods: 78 ONB patients were identified (1994-2019) with original diagnoses dating to 1979.

View Article and Find Full Text PDF